Clin2
NCT07665853Possibly a fitNot yet recruiting

Aspirin timing study for preventing preeclampsia

Preeclampsia

Part of Women’s health & pregnancy clinical trials.

This study looks at whether taking aspirin for a longer or shorter time during pregnancy can better prevent preeclampsia, a serious condition with high blood pressure. It is for pregnant women already taking daily aspirin and found to be at high risk.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
15,160 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You are pregnant with one baby (not twins or more)
  • You had a first-trimester screening test showing high risk for preeclampsia
  • You are currently taking aspirin 150 mg every day
  • You can attend extra blood tests and ultrasound visits
  • You have no medical conditions that make stopping aspirin unsafe

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06952712Not yet recruiting· Phase 3
Aspirin dose for preventing preeclampsia in high-risk obese pregnancies

This study compares two doses of aspirin (150 mg vs 100 mg) to see which is better at preventing preeclampsia, a serious pregnancy complication involving high blood pressure, in women who are obese and at higher risk. If you qualify, you would take one aspirin dose daily during pregnancy.

Guangzhou, Guangdong
NCT07779057Recruiting· Phase 4
Aspirin dose to prevent preeclampsia

This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.

Multan, Punjab Province
NCT05709483Recruiting· Early Phase 1
Aspirin plan test to predict who avoids preeclampsia

This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.

New York, New York
NCT06802861Recruiting
Aspirin metabolism in pregnant women at risk of pre-eclampsia

This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.

Knoxville, Tennessee
NCT06468202Recruiting· Phase 4
Aspirin dose study to prevent high blood pressure in pregnancy

This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.

Birmingham, Alabama
NCT06826859Recruiting· Phase 1/Phase 2
Daily aspirin vs split dosing to prevent preeclampsia

This study compares taking a daily low-dose aspirin (a single pill) versus splitting the same dose into two smaller pills many hours apart to see which way better prevents preeclampsia in pregnant people who are at higher risk.

Philadelphia, Pennsylvania

Hear when a new Preeclampsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.